Guylène Le Meur

1.7k total citations
43 papers, 1.0k citations indexed

About

Guylène Le Meur is a scholar working on Molecular Biology, Ophthalmology and Genetics. According to data from OpenAlex, Guylène Le Meur has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 17 papers in Ophthalmology and 17 papers in Genetics. Recurrent topics in Guylène Le Meur's work include Retinal Development and Disorders (21 papers), Virus-based gene therapy research (13 papers) and Retinal Diseases and Treatments (12 papers). Guylène Le Meur is often cited by papers focused on Retinal Development and Disorders (21 papers), Virus-based gene therapy research (13 papers) and Retinal Diseases and Treatments (12 papers). Guylène Le Meur collaborates with scholars based in France, United States and Canada. Guylène Le Meur's co-authors include Michel Weber, Fabienne Rolling, Philippe Moullier, Alexandra Mendes-Madeira, Jack‐Yves Deschamps, Nathalie Provost, Knut Stieger, Delphine Nivard, Marie-Anne Colle and Yann Péréon and has published in prestigious journals such as Ophthalmology, PLoS Medicine and Investigative Ophthalmology & Visual Science.

In The Last Decade

Guylène Le Meur

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guylène Le Meur France 18 860 436 377 166 133 43 1.0k
Hilda Petrs‐Silva Brazil 14 840 1.0× 390 0.9× 214 0.6× 188 1.1× 88 0.7× 35 964
Christine N. Kay United States 13 871 1.0× 372 0.9× 504 1.3× 131 0.8× 212 1.6× 45 1.2k
Alexandra Mendes-Madeira France 14 706 0.8× 393 0.9× 246 0.7× 168 1.0× 86 0.6× 22 804
Markus Groppe United Kingdom 14 1.2k 1.4× 313 0.7× 843 2.2× 123 0.7× 350 2.6× 23 1.4k
Zhangyong Wei United States 12 791 0.9× 436 1.0× 257 0.7× 129 0.8× 91 0.7× 13 1.0k
Sanford L. Boye United States 11 625 0.7× 369 0.8× 110 0.3× 112 0.7× 44 0.3× 14 838
Suzanne Yzer Netherlands 21 1.0k 1.2× 356 0.8× 1.4k 3.6× 102 0.6× 683 5.1× 55 1.9k
Tiina Alitalo Finland 20 604 0.7× 332 0.8× 238 0.6× 95 0.6× 207 1.6× 30 964
Frank C. Schlichtenbrede Germany 20 720 0.8× 265 0.6× 910 2.4× 167 1.0× 618 4.6× 50 1.5k
Patrik Schatz Sweden 16 527 0.6× 71 0.2× 535 1.4× 77 0.5× 206 1.5× 62 770

Countries citing papers authored by Guylène Le Meur

Since Specialization
Citations

This map shows the geographic impact of Guylène Le Meur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guylène Le Meur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guylène Le Meur more than expected).

Fields of papers citing papers by Guylène Le Meur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guylène Le Meur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guylène Le Meur. The network helps show where Guylène Le Meur may publish in the future.

Co-authorship network of co-authors of Guylène Le Meur

This figure shows the co-authorship network connecting the top 25 collaborators of Guylène Le Meur. A scholar is included among the top collaborators of Guylène Le Meur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guylène Le Meur. Guylène Le Meur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebranchu, Pierre, et al.. (2024). One-year risk of multiple sclerosis after a first episode of optic neuritis according to modern diagnosis criteria. Multiple Sclerosis and Related Disorders. 93. 106213–106213. 1 indexed citations
2.
Dhaenens, Claire‐Marie, Isabelle Audo, A. Lecleire–Collet, et al.. (2024). The phenotypic spectrum of CEP250 gene variants. Ophthalmic Genetics. 46(4). 354–361. 1 indexed citations
3.
Leclère, Brice, et al.. (2024). Unplanned 30‐day readmission rate after ophthalmological surgery as a quality‐of‐care indicator. Acta Ophthalmologica. 102(5). e789–e796.
4.
Zanlonghi, Xavier, et al.. (2024). Variable expressivity of the autosomal dominant vitreoretinochoroidopathy (ADVIRC) phenotype associated with a novel variant in BEST1. Ophthalmic Genetics. 45(5). 470–475. 1 indexed citations
5.
Caillet, Pascal, Guylène Le Meur, Michel Weber, et al.. (2024). Learning curves of novice residents on cataract surgery simulator: the E3CAPS pedagogic study. BMC Medical Education. 24(1). 1078–1078. 1 indexed citations
6.
Jossic, Frédérique, et al.. (2024). Fatal child abuse detected by systematic post-mortem fundus photograph in sudden death in infancy. International Journal of Legal Medicine. 138(5). 1867–1872.
7.
Goronflot, Thomas, et al.. (2023). Assessing retinal hemorrhages with non-invasive post-mortem fundus photographs in sudden unexpected death in infancy. International Journal of Legal Medicine. 137(3). 913–923. 2 indexed citations
8.
Massé, Hélène, et al.. (2023). Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study. Ophthalmology and Therapy. 12(5). 2781–2792. 3 indexed citations
9.
Pierrat, Véronique, G. Caputo, Elsa Kermorvant‐Duchemin, et al.. (2022). Ophthalmological Impairments at Five and a Half Years after Preterm Birth: EPIPAGE-2 Cohort Study. Journal of Clinical Medicine. 11(8). 2139–2139. 3 indexed citations
10.
Kermorvant‐Duchemin, Elsa, Guylène Le Meur, Frank Plaisant, et al.. (2020). Thresholds of glycemia, insulin therapy, and risk for severe retinopathy in premature infants: A cohort study. PLoS Medicine. 17(12). e1003477–e1003477. 18 indexed citations
11.
Tshilenge, Kizito‐Tshitoko, Baptiste Ameline, Michel Weber, et al.. (2016). Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman Primates. Human Gene Therapy Methods. 27(3). 122–134. 28 indexed citations
12.
Meunier, Isabelle, Gaël Manès, Béatrice Bocquet, et al.. (2014). Frequency and Clinical Pattern of Vitelliform Macular Dystrophy Caused by Mutations of Interphotoreceptor Matrix IMPG1 and IMPG2 Genes. Ophthalmology. 121(12). 2406–2414. 55 indexed citations
13.
Meur, Guylène Le, Pierre Lebranchu, Yann Péréon, et al.. (2013). Gene therapy in Leber congenital amaurosis due to rpe mutations: results of the first six patients included in a clinical trial. Investigative Ophthalmology & Visual Science. 54(15). 5969–5969. 1 indexed citations
14.
Daïen, Vincent, et al.. (2013). Determinants of Ocular Deviation in Esotropic Subjects Under General Anesthesia. Journal of Pediatric Ophthalmology & Strabismus. 50(3). 155–160. 1 indexed citations
15.
Lhériteau, Elsa, Michel Weber, Guylène Le Meur, et al.. (2012). Restoration of Vision in the pde6β-deficient Dog, a Large Animal Model of Rod-cone Dystrophy. Molecular Therapy. 20(11). 2019–2030. 50 indexed citations
16.
Meur, Guylène Le, Pierre Lebranchu, Yann Péréon, et al.. (2012). Efficacy and safety of gene therapy with AAV4 in childhood blindness due to rpe65 mutations. Acta Ophthalmologica. 90(s249). 0–0. 4 indexed citations
17.
Stieger, Knut, Josef Schroeder, Nathalie Provost, et al.. (2008). Detection of Intact rAAV Particles up to 6 Years After Successful Gene Transfer in the Retina of Dogs and Primates. Molecular Therapy. 17(3). 516–523. 73 indexed citations
18.
Rolling, Fabienne, Guylène Le Meur, Knut Stieger, et al.. (2006). Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.. PubMed. 161(10-12). 497–508; discussion 508. 18 indexed citations
19.
20.
Provost, Nathalie, Guylène Le Meur, Michel Weber, et al.. (2004). Biodistribution of rAAV Vectors Following Intraocular Administration: Evidence for the Presence and Persistence of Vector DNA in the Optic Nerve and in the Brain. Molecular Therapy. 11(2). 275–283. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilda Petrs‐Silva Breakdown of academic impact, for papers by Christine N. Kay Breakdown of academic impact, for papers by Alexandra Mendes-Madeira Breakdown of academic impact, for papers by Markus Groppe Breakdown of academic impact, for papers by Zhangyong Wei Breakdown of academic impact, for papers by Sanford L. Boye Breakdown of academic impact, for papers by Suzanne Yzer Breakdown of academic impact, for papers by Tiina Alitalo Breakdown of academic impact, for papers by Frank C. Schlichtenbrede Breakdown of academic impact, for papers by Patrik Schatz
Rankless by CCL
2026